Azzur Group and BioSPEQ Announce Merger - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Azzur Group and BioSPEQ Announce Merger


PTSM: Pharmaceutical Technology Sourcing and Management
Volume 10, Issue 5

Azzur Group and BioSPEQ, a California-based consulting firm, have merged to create a union that will provide consulting services and project resources within the QA, laboratory, clinical, information technology, business processes, manufacturing, operations, and R&D settings.

The Azzur-BioSPEQ merger is the latest in a series of new developments for Azzur Group. Earlier this month, the company acquired Azot and formed Azzur Engineering.

Azzur Group’s main office is located in Willow Grove, PA, with additional offices in Frederick, MD, San Antonio, TX, Cambridge, MA, Cary, NC and Palo Alto, CA. BioSPEQ is headquartered in Irvine, CA with additional offices in Lexington, MA and San Diego, CA.

Source: Azzur Group

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
Source: PTSM: Pharmaceutical Technology Sourcing and Management,
Click here